Live feed
Filing
SC 13G/A
SC 13G/A0001193125-23-096247·AMERIPRISE FINANCIAL INC
Schedule 13G ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2023-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 18.2200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-096247
- Form type
- SC 13G/A
- Filer
- AMERIPRISE FINANCIAL INC
- CIK
- CIK 820027
- Filed
- Apr 10, 2023
- Reporting period
- Feb 28, 2023
- Description
- Schedule 13G beneficial ownership